Ipca Labs Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for IPCA LABS LTD, and what generic and branded alternatives to IPCA LABS LTD drugs are available?
IPCA LABS LTD has twenty-one approved drugs.
Drugs and US Patents for Ipca Labs Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ipca Labs Ltd | LOSARTAN POTASSIUM | losartan potassium | TABLET;ORAL | 200290-003 | Aug 30, 2013 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ipca Labs Ltd | WARFARIN SODIUM | warfarin sodium | TABLET;ORAL | 200104-006 | Jun 27, 2013 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ipca Labs Ltd | ESZOPICLONE | eszopiclone | TABLET;ORAL | 206222-003 | Dec 29, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ipca Labs Ltd | METOPROLOL TARTRATE | metoprolol tartrate | TABLET;ORAL | 078459-003 | Jun 17, 2008 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ipca Labs Ltd | ONDANSETRON | ondansetron | TABLET, ORALLY DISINTEGRATING;ORAL | 209389-002 | Oct 30, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ipca Labs Ltd | CHLOROQUINE PHOSPHATE | chloroquine phosphate | TABLET;ORAL | 090610-001 | Dec 3, 2009 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.